American International Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,959
Closed -$698K 244
2024
Q1
$698K Sell
22,959
-198
-0.9% -$6.63K ﹤0.01% 1491
2023
Q4
$826K Sell
23,157
-93
-0.4% -$3.46K ﹤0.01% 1407
2023
Q3
$1.02M Buy
23,250
+827
+4% +$40.3K 0.01% 1223
2023
Q2
$1.11M Buy
22,423
+419
+2% +$19.3K 0.01% 1194
2023
Q1
$912K Buy
22,004
+439
+2% +$18.2K 0.01% 1265
2022
Q4
$957K Sell
21,565
-79
-0.4% -$3.3K 0.01% 1236
2022
Q3
$846K Buy
21,644
+306
+1% +$14K 0.01% 1273
2022
Q2
$872K Sell
21,338
-905
-4% -$42.9K 0.01% 1268
2022
Q1
$1.46M Sell
22,243
-1,565
-7% -$101K 0.01% 1137
2021
Q4
$1.66M Sell
23,808
-713
-3% -$51.8K 0.01% 1154
2021
Q3
$1.71M Sell
24,521
-583
-2% -$44.9K 0.01% 1128
2021
Q2
$1.99K Sell
25,104
-380
-1% -$27.6K 0.01% 1119
2021
Q1
$1.67K Buy
25,484
+67
+0.3% +$4.13K 0.01% 1206
2020
Q4
$1.42K Sell
25,417
-730
-3% -$31.6K 0.01% 1233
2020
Q3
$1.04M Buy
26,147
+2,298
+10% +$97.5K 0.01% 1231
2020
Q2
$1.07M Buy
23,849
+1,354
+6% +$59K 0.01% 1187
2020
Q1
$756K Sell
22,495
-1,300
-5% -$46.7K ﹤0.01% 1231
2019
Q4
$774K Buy
23,795
+364
+2% +$10.4K ﹤0.01% 1462
2019
Q3
$584K Sell
23,431
-164
-0.7% -$4.68K ﹤0.01% 1576
2019
Q2
$704K Buy
23,595
+85
+0.4% +$2.48K ﹤0.01% 1511
2019
Q1
$630K Sell
23,510
-762
-3% -$23.1K ﹤0.01% 1571
2018
Q4
$743K Buy
24,272
+2,027
+9% +$63.1K ﹤0.01% 1441
2018
Q3
$779K Buy
22,245
+402
+2% +$12.7K ﹤0.01% 1605
2018
Q2
$591K Buy
21,843
+1,319
+6% +$31K ﹤0.01% 1718
2018
Q1
$421K Sell
20,524
-1,104
-5% -$19.9K ﹤0.01% 1836
2017
Q4
$394K Buy
21,628
+346
+2% +$6.85K ﹤0.01% 1918
2017
Q3
$476K Buy
21,282
+1,591
+8% +$36K ﹤0.01% 1792
2017
Q2
$478K Buy
19,691
+345
+2% +$7.33K ﹤0.01% 1740
2017
Q1
$370K Buy
19,346
+1,273
+7% +$22.3K ﹤0.01% 1808
2016
Q4
$354K Sell
18,073
-47
-0.3% -$852 ﹤0.01% 1855
2016
Q3
$287K Buy
18,120
+27
+0.1% +$415 ﹤0.01% 1940
2016
Q2
$256K Buy
18,093
+1,478
+9% +$22.5K ﹤0.01% 1972
2016
Q1
$280K Hold
16,615
﹤0.01% 2476
2015
Q4
$373K Sell
16,615
-29
-0.2% -$598 ﹤0.01% 2266
2015
Q3
$365K Buy
16,644
+19
+0.1% +$475 ﹤0.01% 2284
2015
Q2
$410K Sell
16,625
-607
-4% -$13.6K ﹤0.01% 2355
2015
Q1
$353K Hold
17,232
﹤0.01% 2458
2014
Q4
$344K Sell
17,232
-682
-4% -$11.7K ﹤0.01% 2462
2014
Q3
$264K Sell
17,914
-13
-0.1% -$207 ﹤0.01% 2707
2014
Q2
$329K Buy
17,927
+3,693
+26% +$61.5K ﹤0.01% 2554
2014
Q1
$268K Buy
14,234
+342
+2% +$7.01K ﹤0.01% 2591
2013
Q4
$260K Sell
13,892
-139
-1% -$2.02K ﹤0.01% 2557
2013
Q3
$154K Buy
14,031
+1,629
+13% +$16.1K ﹤0.01% 2950
2013
Q2
$118K Buy
+12,402
New +$108K ﹤0.01% 3011

Other funds holding ATRC

American International Group's ATRC Position: Q2 2024 in Review

American International Group sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 22,959 shares — an estimated $698K sold.

American International Group first reported a position in ATRC in Q2 2013 and held it in 44 quarters. The position peaked at $1.71M in Q3 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • American International Group reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 22,959 AtriCure shares in Q2 2024, an estimated $698K.
  • American International Group first reported a position in AtriCure in Q2 2013 and held it in 44 quarters.
  • American International Group's AtriCure position peaked at $1.71M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.